What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ?
Some surgeons have advocated sentinel node biopsy (SNB) for ductal carcinoma in situ (DCIS). The value of the information obtained is not clear. From 1972 to 2005, 564 selected patients with pure DCIS had axillary staging with either SNB or axillary lymph node dissection (ALND). Data were collected...
Gespeichert in:
| Veröffentlicht in: | The American journal of surgery 2006-10, Vol.192 (4), p.455-457 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 457 |
|---|---|
| container_issue | 4 |
| container_start_page | 455 |
| container_title | The American journal of surgery |
| container_volume | 192 |
| creator | Mabry, Helen Giuliano, Armando E. Silverstein, Melvin J. |
| description | Some surgeons have advocated sentinel node biopsy (SNB) for ductal carcinoma in situ (DCIS). The value of the information obtained is not clear.
From 1972 to 2005, 564 selected patients with pure DCIS had axillary staging with either SNB or axillary lymph node dissection (ALND). Data were collected in a prospective database.
Only 2 of 564 patients had positive nodes by hematoxylin and eosin, and they were both in the ALND group. Both patients had mastectomies, were upstaged, received chemotherapy, and survived for more than 10 years without local or distant recurrence. Among 171 patients who had SNB, 10 had isolated tumor cells found by immunohistochemistry. Two patients who underwent SNB had local recurrence, neither developed distant or regional recurrence. Six of 564 patients in the ALND group developed local invasive recurrence and died of metastatic breast cancer, but none of them had positive nodes.
Information from lymph node examination in DCIS patients failed to predict poor outcome. SNB is useful for DCIS in mastectomy, especially with immediate reconstruction. It may be indicated for DCIS at high risk for upgrading to invasive cancer on final excision, but reliable criteria for identifying these tumors are not yet available. |
| doi_str_mv | 10.1016/j.amjsurg.2006.06.028 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68865646</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002961006004211</els_id><sourcerecordid>2729581781</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-3176aed2916467537e9583b2674315c0ddc3e9e731157aa9d1cbab6fb0abbfee3</originalsourceid><addsrcrecordid>eNqFkV-L1TAQxYMo7t2rH0EJiPvWa6Zp0_RpWRb_wYIvio8hTabe1La5JunqfntTbmHBF2FgGPKbw-QcQl4BOwAD8W446GmIS_hxKBkTh7VK-YTsQDZtAVLyp2THGCuLVgC7IJcxDnkEqPhzcgGibWRbyR35-f2oE3WRpiPSez0uSH1P9R83jjo8UOtiRJOcn6kPNOKc3Iwjnb1F2jl_ig_UzfSkk8tPkf526UjtYpIeqdHBuNlPeiWiS8v1C_Ks12PEl1vfk28f3n-9_VTcffn4-fbmrjBVCang0AiNtmxBVKKpeYNtLXlXiqbiUBtmreHYYsMB6kbr1oLpdCf6jumu6xH5nlyddU_B_1owJjW5aDD_aEa_RCWkFHXWzuCbf8DBL2HOtylgHEoQq5F7Up8pE3yMAXt1Cm7K7mRIrVmoQW1ZqDULtVa57r3e1JduQvu4tZmfgbcboKPRYx_0bFx85GRZ1iBW7vrMYTbt3mFQ0WS_DVoXcjjKevefU_4Ct3mrIQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1031216188</pqid></control><display><type>article</type><title>What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ?</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Mabry, Helen ; Giuliano, Armando E. ; Silverstein, Melvin J.</creator><creatorcontrib>Mabry, Helen ; Giuliano, Armando E. ; Silverstein, Melvin J.</creatorcontrib><description>Some surgeons have advocated sentinel node biopsy (SNB) for ductal carcinoma in situ (DCIS). The value of the information obtained is not clear.
From 1972 to 2005, 564 selected patients with pure DCIS had axillary staging with either SNB or axillary lymph node dissection (ALND). Data were collected in a prospective database.
Only 2 of 564 patients had positive nodes by hematoxylin and eosin, and they were both in the ALND group. Both patients had mastectomies, were upstaged, received chemotherapy, and survived for more than 10 years without local or distant recurrence. Among 171 patients who had SNB, 10 had isolated tumor cells found by immunohistochemistry. Two patients who underwent SNB had local recurrence, neither developed distant or regional recurrence. Six of 564 patients in the ALND group developed local invasive recurrence and died of metastatic breast cancer, but none of them had positive nodes.
Information from lymph node examination in DCIS patients failed to predict poor outcome. SNB is useful for DCIS in mastectomy, especially with immediate reconstruction. It may be indicated for DCIS at high risk for upgrading to invasive cancer on final excision, but reliable criteria for identifying these tumors are not yet available.</description><identifier>ISSN: 0002-9610</identifier><identifier>EISSN: 1879-1883</identifier><identifier>DOI: 10.1016/j.amjsurg.2006.06.028</identifier><identifier>PMID: 16978948</identifier><identifier>CODEN: AJSUAB</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Axilla ; Biological and medical sciences ; Biopsy ; Breast ; Breast cancer ; Breast Neoplasms - pathology ; Breast Neoplasms - therapy ; Cancer ; Carcinoma, Intraductal, Noninfiltrating - pathology ; Carcinoma, Intraductal, Noninfiltrating - therapy ; Chemotherapy ; DCIS ; Dissection ; Ductal carcinoma in situ ; Female ; Follow-Up Studies ; General aspects ; Humans ; Lymph Node Excision ; Lymphatic system ; Medical sciences ; Middle Aged ; Neoplasm Staging ; Predictive Value of Tests ; Retrospective Studies ; Sentinel Lymph Node Biopsy ; Sentinel node biopsy ; SNB ; Surgery ; Treatment Outcome</subject><ispartof>The American journal of surgery, 2006-10, Vol.192 (4), p.455-457</ispartof><rights>2006 Excerpta Medica Inc.</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-3176aed2916467537e9583b2674315c0ddc3e9e731157aa9d1cbab6fb0abbfee3</citedby><cites>FETCH-LOGICAL-c421t-3176aed2916467537e9583b2674315c0ddc3e9e731157aa9d1cbab6fb0abbfee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1031216188?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>309,310,314,780,784,789,790,3550,23930,23931,25140,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18225168$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16978948$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mabry, Helen</creatorcontrib><creatorcontrib>Giuliano, Armando E.</creatorcontrib><creatorcontrib>Silverstein, Melvin J.</creatorcontrib><title>What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ?</title><title>The American journal of surgery</title><addtitle>Am J Surg</addtitle><description>Some surgeons have advocated sentinel node biopsy (SNB) for ductal carcinoma in situ (DCIS). The value of the information obtained is not clear.
From 1972 to 2005, 564 selected patients with pure DCIS had axillary staging with either SNB or axillary lymph node dissection (ALND). Data were collected in a prospective database.
Only 2 of 564 patients had positive nodes by hematoxylin and eosin, and they were both in the ALND group. Both patients had mastectomies, were upstaged, received chemotherapy, and survived for more than 10 years without local or distant recurrence. Among 171 patients who had SNB, 10 had isolated tumor cells found by immunohistochemistry. Two patients who underwent SNB had local recurrence, neither developed distant or regional recurrence. Six of 564 patients in the ALND group developed local invasive recurrence and died of metastatic breast cancer, but none of them had positive nodes.
Information from lymph node examination in DCIS patients failed to predict poor outcome. SNB is useful for DCIS in mastectomy, especially with immediate reconstruction. It may be indicated for DCIS at high risk for upgrading to invasive cancer on final excision, but reliable criteria for identifying these tumors are not yet available.</description><subject>Axilla</subject><subject>Biological and medical sciences</subject><subject>Biopsy</subject><subject>Breast</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - pathology</subject><subject>Breast Neoplasms - therapy</subject><subject>Cancer</subject><subject>Carcinoma, Intraductal, Noninfiltrating - pathology</subject><subject>Carcinoma, Intraductal, Noninfiltrating - therapy</subject><subject>Chemotherapy</subject><subject>DCIS</subject><subject>Dissection</subject><subject>Ductal carcinoma in situ</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>General aspects</subject><subject>Humans</subject><subject>Lymph Node Excision</subject><subject>Lymphatic system</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Predictive Value of Tests</subject><subject>Retrospective Studies</subject><subject>Sentinel Lymph Node Biopsy</subject><subject>Sentinel node biopsy</subject><subject>SNB</subject><subject>Surgery</subject><subject>Treatment Outcome</subject><issn>0002-9610</issn><issn>1879-1883</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkV-L1TAQxYMo7t2rH0EJiPvWa6Zp0_RpWRb_wYIvio8hTabe1La5JunqfntTbmHBF2FgGPKbw-QcQl4BOwAD8W446GmIS_hxKBkTh7VK-YTsQDZtAVLyp2THGCuLVgC7IJcxDnkEqPhzcgGibWRbyR35-f2oE3WRpiPSez0uSH1P9R83jjo8UOtiRJOcn6kPNOKc3Iwjnb1F2jl_ig_UzfSkk8tPkf526UjtYpIeqdHBuNlPeiWiS8v1C_Ks12PEl1vfk28f3n-9_VTcffn4-fbmrjBVCang0AiNtmxBVKKpeYNtLXlXiqbiUBtmreHYYsMB6kbr1oLpdCf6jumu6xH5nlyddU_B_1owJjW5aDD_aEa_RCWkFHXWzuCbf8DBL2HOtylgHEoQq5F7Up8pE3yMAXt1Cm7K7mRIrVmoQW1ZqDULtVa57r3e1JduQvu4tZmfgbcboKPRYx_0bFx85GRZ1iBW7vrMYTbt3mFQ0WS_DVoXcjjKevefU_4Ct3mrIQ</recordid><startdate>20061001</startdate><enddate>20061001</enddate><creator>Mabry, Helen</creator><creator>Giuliano, Armando E.</creator><creator>Silverstein, Melvin J.</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20061001</creationdate><title>What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ?</title><author>Mabry, Helen ; Giuliano, Armando E. ; Silverstein, Melvin J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-3176aed2916467537e9583b2674315c0ddc3e9e731157aa9d1cbab6fb0abbfee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Axilla</topic><topic>Biological and medical sciences</topic><topic>Biopsy</topic><topic>Breast</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - pathology</topic><topic>Breast Neoplasms - therapy</topic><topic>Cancer</topic><topic>Carcinoma, Intraductal, Noninfiltrating - pathology</topic><topic>Carcinoma, Intraductal, Noninfiltrating - therapy</topic><topic>Chemotherapy</topic><topic>DCIS</topic><topic>Dissection</topic><topic>Ductal carcinoma in situ</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>General aspects</topic><topic>Humans</topic><topic>Lymph Node Excision</topic><topic>Lymphatic system</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Predictive Value of Tests</topic><topic>Retrospective Studies</topic><topic>Sentinel Lymph Node Biopsy</topic><topic>Sentinel node biopsy</topic><topic>SNB</topic><topic>Surgery</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mabry, Helen</creatorcontrib><creatorcontrib>Giuliano, Armando E.</creatorcontrib><creatorcontrib>Silverstein, Melvin J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mabry, Helen</au><au>Giuliano, Armando E.</au><au>Silverstein, Melvin J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ?</atitle><jtitle>The American journal of surgery</jtitle><addtitle>Am J Surg</addtitle><date>2006-10-01</date><risdate>2006</risdate><volume>192</volume><issue>4</issue><spage>455</spage><epage>457</epage><pages>455-457</pages><issn>0002-9610</issn><eissn>1879-1883</eissn><coden>AJSUAB</coden><abstract>Some surgeons have advocated sentinel node biopsy (SNB) for ductal carcinoma in situ (DCIS). The value of the information obtained is not clear.
From 1972 to 2005, 564 selected patients with pure DCIS had axillary staging with either SNB or axillary lymph node dissection (ALND). Data were collected in a prospective database.
Only 2 of 564 patients had positive nodes by hematoxylin and eosin, and they were both in the ALND group. Both patients had mastectomies, were upstaged, received chemotherapy, and survived for more than 10 years without local or distant recurrence. Among 171 patients who had SNB, 10 had isolated tumor cells found by immunohistochemistry. Two patients who underwent SNB had local recurrence, neither developed distant or regional recurrence. Six of 564 patients in the ALND group developed local invasive recurrence and died of metastatic breast cancer, but none of them had positive nodes.
Information from lymph node examination in DCIS patients failed to predict poor outcome. SNB is useful for DCIS in mastectomy, especially with immediate reconstruction. It may be indicated for DCIS at high risk for upgrading to invasive cancer on final excision, but reliable criteria for identifying these tumors are not yet available.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>16978948</pmid><doi>10.1016/j.amjsurg.2006.06.028</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9610 |
| ispartof | The American journal of surgery, 2006-10, Vol.192 (4), p.455-457 |
| issn | 0002-9610 1879-1883 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68865646 |
| source | MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland |
| subjects | Axilla Biological and medical sciences Biopsy Breast Breast cancer Breast Neoplasms - pathology Breast Neoplasms - therapy Cancer Carcinoma, Intraductal, Noninfiltrating - pathology Carcinoma, Intraductal, Noninfiltrating - therapy Chemotherapy DCIS Dissection Ductal carcinoma in situ Female Follow-Up Studies General aspects Humans Lymph Node Excision Lymphatic system Medical sciences Middle Aged Neoplasm Staging Predictive Value of Tests Retrospective Studies Sentinel Lymph Node Biopsy Sentinel node biopsy SNB Surgery Treatment Outcome |
| title | What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T13%3A06%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=What%20is%20the%20value%20of%20axillary%20dissection%20or%20sentinel%20node%20biopsy%20in%20patients%20with%20ductal%20carcinoma%20in%20situ?&rft.jtitle=The%20American%20journal%20of%20surgery&rft.au=Mabry,%20Helen&rft.date=2006-10-01&rft.volume=192&rft.issue=4&rft.spage=455&rft.epage=457&rft.pages=455-457&rft.issn=0002-9610&rft.eissn=1879-1883&rft.coden=AJSUAB&rft_id=info:doi/10.1016/j.amjsurg.2006.06.028&rft_dat=%3Cproquest_cross%3E2729581781%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1031216188&rft_id=info:pmid/16978948&rft_els_id=S0002961006004211&rfr_iscdi=true |